Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands
Eli Lilly, a US pharmaceutical company, is increasing the UK price of its weight loss medication Mounjaro by up to 170%. This comes after former US President Donald Trump put pressure on the pharmaceutical industry to make drugs more affordable for Americans. The price of a month's supply of the highest dose of Mounjaro will rise from £122 to £330 in the UK starting from September. Eli Lilly has attributed this price hike to Trump's demands for the industry to make drugs more accessible and cheaper for US consumers, even if it means raising prices in other markets like the UK. The article highlights the ongoing tension between the pharmaceutical industry's pricing practices and the efforts by governments, like the US under Trump, to make essential medications more affordable for their citizens.
Note: This is an AI-generated summary of the original article. For the full story, please visit the source link below.
